JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M313435200 on April 21, 2004

J. Biol. Chem., Vol. 279, Issue 26, 27549-27559, June 25, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/26/27549    most recent
M313435200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fujioka, S.
Right arrow Articles by Chiao, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fujioka, S.
Right arrow Articles by Chiao, P. J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Stabilization of p53 Is a Novel Mechanism for Proapoptotic Function of NF-{kappa}B*

Shuichi Fujioka{ddagger}, Christian Schmidt{ddagger}, Guido M. Sclabas{ddagger}§, Zhongkui Li{ddagger}, Hélène Pelicano¶, Bailu Peng{ddagger}, Alice Yao||, Jiangong Niu**, Wei Zhang¶, Douglas B. Evans{ddagger}, James L. Abbruzzese{ddagger}{ddagger}, Peng Huang¶, and Paul J. Chiao{ddagger}**§§¶¶

From the Departments of {ddagger}Surgical Oncology, {ddagger}{ddagger}Gastrointestinal Medical Oncology, and §§Molecular & Cellular Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, the §Visceral and Transplantation Surgery, Inselspital, University of Bern, 3010 Bern, Switzerland, the Department of Molecular Pathology and ||Summer Student Program, The University of Texas-Houston Health Science Center, Houston, Texas 77030, and the **Program in Cancer Biology, The University of Texas Graduate School of Biomedical Sciences at Houston, Houston, Texas 77030

Both pro- and antiapoptotic activities of NF-{kappa}B transcription factor have been observed; however, less is known about the mechanism by which NF-{kappa}B induces apoptosis. To elucidate how NF-{kappa}B regulates proapoptotic signaling, we performed functional analyses using wild-type, ikk1-/-, ikk2-/-, rela-/- murine fibroblasts, MDAPanc-28/Puro, MDAPanc-28/I{kappa}B{alpha}M, and HCT116/p53+/+ and HCT116/p53-/- cells with investigational anticancer agent doxycycline as a superoxide inducer for generating apoptotic stimulus. In this report, we show that doxycycline increased superoxide generation and subsequently activated NF-{kappa}B, which in turn up-regulated p53 expression and increased the stability and DNA binding activity of p53. Consequently, NF-{kappa}B-dependent p53 activity induced the expression of p53-regulated genes PUMA and p21waf1 as well as apoptosis. Importantly, lack of RelA, IKK, and p53 as well as expression of a dominant negative I{kappa}B{alpha} (I{kappa}B{alpha}M) inhibited NF-{kappa}B-dependent p53 activation and apoptosis. The doxycycline-induced NF-{kappa}B activation was not inhibited in HCT116/p53-/- cells. Our results demonstrate that NF-{kappa}B plays an essential role in activation of wild-type p53 tumor suppressor to initiate proapoptotic signaling in response to overgeneration of superoxide. Thus, these findings reveal a mechanism of NF-{kappa}B-regulated proapoptotic signaling.


Received for publication, December 9, 2003 , and in revised form, March 11, 2004.

* The work was supported by NCI, National Institutes of Health Grants CA78778-01 and PA-98-029 and by a grant from the Lockton Fund for Pancreatic Cancer Research. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

¶¶ To whom correspondence should be addressed: Dept. of Surgical Oncology and Department of Molecular & Cellular Oncology, Unit 107, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030. Tel.: 713-794-1030; Fax: 713-794-4830; E-mail: pjchiao{at}mail.mdanderson.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
EndocrinologyHome page
S. Lu, K. A. Becker, M. J. Hagen, H. Yan, A. L. Roberts, L. A. Mathews, S. S. Schneider, H. T. Siegelmann, K. J. MacBeth, S. M. Tirrell, et al.
Transcriptional Responses to Estrogen and Progesterone in Mammary Gland Identify Networks Regulating p53 Activity
Endocrinology, October 1, 2008; 149(10): 4809 - 4820.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. P. Chapoval, A. Al-Garawi, J. M. Lora, I. Strickland, B. Ma, P. J. Lee, R. J. Homer, S. Ghosh, A. J. Coyle, and J. A. Elias
Inhibition of NF-{kappa}B Activation Reduces the Tissue Effects of Transgenic IL-13
J. Immunol., November 15, 2007; 179(10): 7030 - 7041.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
N. Kawamata, J. Chen, and H. P. Koeffler
Suberoylanilide hydroxamic acid (SAHA; vorinostat) suppresses translation of cyclin D1 in mantle cell lymphoma cells
Blood, October 1, 2007; 110(7): 2667 - 2673.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Furuya, T. Ozaki, T. Hanamoto, M. Hosoda, S. Hayashi, P. A. Barker, K. Takano, M. Matsumoto, and A. Nakagawara
Stabilization of p73 by Nuclear I{kappa}B Kinase-{alpha} Mediates Cisplatin-induced Apoptosis
J. Biol. Chem., June 22, 2007; 282(25): 18365 - 18378.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. M. Alvira, A. Abate, G. Yang, P. A. Dennery, and M. Rabinovitch
Nuclear Factor-{kappa}B Activation in Neonatal Mouse Lung Protects against Lipopolysaccharide-induced Inflammation
Am. J. Respir. Crit. Care Med., April 15, 2007; 175(8): 805 - 815.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
G. D. Minsavage and J. F. Dillman III
Bifunctional Alkylating Agent-Induced p53 and Nonclassical Nuclear Factor {kappa}B Responses and Cell Death Are Altered by Caffeic Acid Phenethyl Ester: A Potential Role for Antioxidant/Electrophilic Response-Element Signaling
J. Pharmacol. Exp. Ther., April 1, 2007; 321(1): 202 - 212.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
D. Bonofiglio, S. Aquila, S. Catalano, S. Gabriele, M. Belmonte, E. Middea, H. Qi, C. Morelli, M. Gentile, M. Maggiolini, et al.
Peroxisome Proliferator-Activated Receptor-{gamma} Activates p53 Gene Promoter Binding to the Nuclear Factor-{kappa}B Sequence in Human MCF7 Breast Cancer Cells
Mol. Endocrinol., December 1, 2006; 20(12): 3083 - 3092.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
F. O. Baxter, P. J. Came, K. Abell, B. Kedjouar, M. Huth, K. Rajewsky, M. Pasparakis, and C. J. Watson
IKK{beta}/2 induces TWEAK and apoptosis in mammary epithelial cells
Development, September 1, 2006; 133(17): 3485 - 3494.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
G. P. Collett and F. C. Campbell
Overexpression of p65/RelA potentiates curcumin-induced apoptosis in HCT116 human colon cancer cells
Carcinogenesis, June 1, 2006; 27(6): 1285 - 1291.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
P. Hu, Z. Han, A. D. Couvillon, R. J. Kaufman, and J. H. Exton
Autocrine Tumor Necrosis Factor Alpha Links Endoplasmic Reticulum Stress to the Membrane Death Receptor Pathway through IRE1{alpha}-Mediated NF-{kappa}B Activation and Down-Regulation of TRAF2 Expression
Mol. Cell. Biol., April 15, 2006; 26(8): 3071 - 3084.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
S. F. Liu and A. B. Malik
NF-{kappa}B activation as a pathological mechanism of septic shock and inflammation
Am J Physiol Lung Cell Mol Physiol, April 1, 2006; 290(4): L622 - L645.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. Sun, D. E. C. Wilkins, M. R. Anver, T. J. Sayers, A. Panoskaltsis-Mortari, B. R. Blazar, L. A. Welniak, and W. J. Murphy
Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
Blood, November 1, 2005; 106(9): 3293 - 3299.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Shim and T. E. Eling
Protein Kinase C-dependent Regulation of NAG-1/Placental Bone Morphogenic Protein/MIC-1 Expression in LNCaP Prostate Carcinoma Cells
J. Biol. Chem., May 13, 2005; 280(19): 18636 - 18642.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Li, J. Niu, T. Uwagawa, B. Peng, and P. J. Chiao
Function of Polo-like Kinase 3 in NF-{kappa}B-mediated Proapoptotic Response
J. Biol. Chem., April 29, 2005; 280(17): 16843 - 16850.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.